Consistent with this result, JIB04 treatment reduced both the BCKDHA and EGFR protein levels in these NSCLC cells but did not reduce the protein level of BCKDHA in EGFR-WT NSCLC cells (Fig. 4d). The gene discussed is BCKDHA; the disease is non-small cell lung carcinoma.